ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Otsuka expects to shell out $120M to settle Avanir's Nuedexta marketing probe
February 24, 2019Avanir has faced intense scrutiny over its marketing of neurological treatment Nuedexta, and now the company is nearing a deal with the Department of Justice to resolve the government's probe. -
Avanir Terminates License Agreement with Optinose for ONZETRA Xsail
December 12, 2018Avanir Pharmaceuticals announced that it will terminate the license agreement with Optinose for intranasal migraine medication ONZETRA Xsail (sumatriptan nasal powder).....
Pharma Sources Insight January 2025
